Hypertension and Pre-eclampsia in Pregnancy: Safe Drugs and Magnesium
Pregnancy rewrites the pharmacology rulebook. A blood-pressure drug that is first-line for everyone else can maim a fetus; a salt that no one thinks of as an anticonvulsant becomes the single most important drug on the labour ward. Hypertensive disorders of pregnancy are less about pushing a number down than about choosing agents that will not harm the baby — and knowing that when the mother is on the edge of a seizure, the answer is not a benzodiazepine but magnesium. Get the safe list, the teratogen list, and magnesium toxicity right, and you have the whole chapter.
A 29-year-old woman, 34 weeks pregnant with her first child, arrives with a pounding headache, flashing lights in her vision, and swollen hands. Her blood pressure is 168/112 and the dipstick shows heavy proteinuria. This is not simply "high blood pressure" — it is pre-eclampsia, a multisystem disorder driven by a sick placenta, and the headache and visual sparks are warning shots that the brain is irritable. The team does two things at once. They bring the pressure down with a drug proven safe for the fetus — not the ACE inhibitor they might reach for in anyone else, which would poison the baby's kidneys. And they start an infusion of magnesium sulfate, not to lower the pressure, but to stop the seizure that is threatening to come. The definitive cure, everyone knows, is to deliver the baby.
A spectrum, not one disease
High blood pressure in pregnancy comes in three flavours, and the difference dictates the danger. Chronic hypertension is high pressure that predates the pregnancy or appears before 20 weeks — the woman was hypertensive already. Gestational hypertension is new high pressure after 20 weeks with no other features; it often behaves benignly but must be watched, because a fraction will tip over. Pre-eclampsia is the dangerous one: new hypertension after 20 weeks plus evidence of end-organ involvement — classically proteinuria (the leaking kidney), but equally a rising creatinine, deranged liver enzymes, a falling platelet count, or neurological signs. It is not a blood-pressure problem with a kidney complication; it is a multisystem placental disorder that happens to raise the pressure. Left to progress, pre-eclampsia can escalate to eclampsia — the onset of generalized tonic-clonic seizures — which is an obstetric emergency.
Think of the placenta as a faulty pressure valve wired into the mother's whole circulation. In pre-eclampsia the valve was built badly in early pregnancy — the placental blood vessels never widened as they should — so it leaks distress signals into the bloodstream that inflame and constrict vessels body-wide. That is why lowering the mother's blood pressure treats the reading but not the disease: you are turning down the gauge, not fixing the valve. Only removing the valve — delivering the placenta — cures it.
The safe antihypertensives — the high-yield list
In pregnancy you do not choose the most powerful drug; you choose the one with the longest safety record. Three oral agents dominate. Labetalol is first-line: a combined alpha- and beta-blocker (its alpha-blockade softens the reflex that a pure beta-blocker would trigger), available orally for maintenance and intravenously for acute control. Nifedipine — a dihydropyridine calcium-channel blocker, used as the modified-release preparation — relaxes vascular smooth muscle and is an excellent alternative or add-on. Methyldopa is the veteran: a central alpha-2 agonist that reduces sympathetic outflow from the brainstem (the same class as clonidine), with the longest safety record of all in pregnancy — but a slow onset over days and a notable tendency to cause sedation and depression, which limits its use, especially postpartum. For acute, severe hypertension needing rapid control, intravenous hydralazine (a direct arteriolar vasodilator) joins IV labetalol and nifedipine as an accepted option. The mechanisms of all of these are taught in full in the Cardiovascular section — here the point is simply which of them are safe for the fetus.
Maintenance (oral): labetalol (combined α/β-blocker, first-line), nifedipine MR (calcium-channel blocker), methyldopa (central α-2 agonist — safe but slow, sedating, can cause depression). Acute severe hypertension (IV): labetalol, hydralazine, or oral/IV nifedipine. All three maintenance drugs are also compatible with breastfeeding, so a woman can usually continue them after delivery. The target is to bring severe hypertension safely down — not to normalize the pressure completely, because the placenta still needs perfusion.
The teratogens: drugs you must never give
This is the classic exam point. ACE inhibitors and ARBs — the workhorses of hypertension outside pregnancy — are absolutely contraindicated in it. By blocking the renin-angiotensin system on which the fetal kidney depends, they cause fetal renal damage, a collapse in fetal urine output and therefore oligohydramnios (too little amniotic fluid), skull ossification defects, limb contractures and, in the worst case, fetal death. A woman with chronic hypertension who is planning pregnancy should be switched off these agents beforehand. Diuretics are generally avoided too — they can blunt the plasma-volume expansion a healthy pregnancy needs, and pre-eclampsia is already a state of contracted intravascular volume. The principle here belongs to the Principles-of-pharmacology chapter on teratogenicity: a drug's benefit in one patient says nothing about its safety in a fetus, whose developing organs follow rules of their own.
- Pre-eclampsia = new hypertension after 20 weeks + end-organ involvement (proteinuria, deranged LFTs, low platelets, neuro signs); it is a multisystem placental disorder.
- Safe maintenance antihypertensives: labetalol (first-line), nifedipine MR, methyldopa.
- Acute severe hypertension: IV labetalol, IV hydralazine, or nifedipine.
- Never in pregnancy: ACE inhibitors and ARBs — fetal renal damage, oligohydramnios, skull defects.
- Methyldopa is safe but slow in onset and can cause sedation/depression — avoid it postpartum.
- Delivery of the placenta is the only definitive cure for pre-eclampsia.
Prevention: low-dose aspirin
Because pre-eclampsia is seeded early — in the faulty formation of placental vessels — the window to prevent it is early too. In women at high risk (previous pre-eclampsia, chronic hypertension, chronic kidney disease, diabetes, autoimmune disease, or several moderate risk factors together), low-dose aspirin started from early pregnancy — typically by the end of the first trimester — measurably reduces the incidence of pre-eclampsia and its complications. The mechanism is the familiar antiplatelet action covered in the Antithrombotics / Haematology section: at low dose aspirin irreversibly inhibits platelet COX-1, tilting the thromboxane–prostacyclin balance in a way that favours healthier placental perfusion. It is one of the few genuinely preventive drugs in obstetrics, and a favourite of examiners precisely because the timing (start early) is the whole point.
Magnesium sulfate: the drug of the labour ward
When pre-eclampsia turns severe or a seizure looms, one drug stands apart — and it is not an anticonvulsant. Magnesium sulfate is the drug of choice both to prevent seizures in severe pre-eclampsia and to treat the seizures of eclampsia — and it outperforms the standard anticonvulsants at this specific job. This is one of medicine's cleaner evidence stories: the Magpie trial showed magnesium roughly halved the risk of eclampsia in severe pre-eclampsia, and the Collaborative Eclampsia Trial showed that in a woman who has already fitted, magnesium prevents further seizures better than diazepam or phenytoin. So the reflex "seizure → benzodiazepine" is wrong here: eclampsia is treated with magnesium. Its exact mechanism is not fully settled but is thought to involve cerebral vasodilatation and blockade of NMDA receptors, calming the irritable, vasospastic brain rather than acting as a classical antiepileptic. A loading dose is given intravenously, followed by a maintenance infusion.
Magnesium has a second, distinct obstetric use that shares the very same drug: given to the mother when very preterm delivery is expected, it provides fetal neuroprotection, reducing the risk of cerebral palsy in the baby. That role is covered in the Tocolytics chapter — worth remembering that the same ampoule serves two purposes. In pre-eclampsia, alongside magnesium and antihypertensives, fluids are given cautiously: these women are prone to pulmonary oedema, so aggressive fluid loading is dangerous. But none of these measures is the cure. The definitive treatment of pre-eclampsia and eclampsia is delivery — everything else is buying time and safety until the placenta can be removed.
Magnesium sulfate is not treating epilepsy — it is treating a placenta-driven, vasospastic brain, which is why it beats "real" anticonvulsants at exactly this task and nowhere else. Hold that distinction and two exam traps disappear: you will not reach for diazepam in eclampsia, and you will not expect magnesium to control an ordinary epileptic seizure. The same logic explains why magnesium is dosed and monitored like a controlled toxin, not titrated to a seizure count: its therapeutic window is narrow.
Magnesium toxicity and its antidote
The same magnesium that stops seizures can stop breathing — safety is the whole discipline. Magnesium is cleared by the kidneys, and in pre-eclampsia renal function is often impaired — so the drug can accumulate to toxic levels. The signs progress in a recognizable order, and this sequence is a gift to examiners. The earliest and most useful warning is loss of the deep tendon reflexes: an absent knee-jerk means "stop and reassess." Push further and you get respiratory depression, then cardiac conduction problems and, at the extreme, cardiac arrest. So monitoring is clinical and continuous: deep tendon reflexes, respiratory rate, and urine output (because falling urine output means the drug is no longer being cleared and levels will climb). If toxicity develops, the antidote is intravenous calcium gluconate — calcium directly antagonizes magnesium at the neuromuscular junction and in the heart. This links straight to the Toxicology section's logic of specific antidotes: calcium gluconate for magnesium sits alongside naloxone for opioids and flumazenil for benzodiazepines as an antidote you are expected to name on sight.
- Magnesium sulfate prevents AND treats eclamptic seizures — drug of choice, superior to diazepam/phenytoin (Magpie, Collaborative Eclampsia Trial).
- It is not a classical anticonvulsant — it calms a vasospastic, placenta-driven brain.
- Toxicity order: loss of deep tendon reflexes → respiratory depression → cardiac arrest.
- Monitor reflexes, respiratory rate, and urine output (magnesium is renally cleared).
- Antidote = IV calcium gluconate; magnesium also gives fetal neuroprotection in preterm delivery.
- Low-dose aspirin from early pregnancy prevents pre-eclampsia in high-risk women.
- Giving an ACE inhibitor or ARB to a pregnant woman — these are teratogenic (fetal renal damage, oligohydramnios, skull defects) and must be stopped, ideally before conception.
- Reaching for a benzodiazepine for an eclamptic seizure — magnesium sulfate, not diazepam or phenytoin, is the drug of choice.
- Continuing magnesium without watching reflexes and urine output — an absent knee-jerk or falling urine output is the early warning of accumulating, potentially fatal toxicity.
A woman with severe pre-eclampsia is on a magnesium sulfate infusion. On review her patellar reflexes are absent and her respiratory rate has fallen to 9/min. What is the most appropriate immediate action?
- Hypertension in pregnancy spans chronic, gestational, and pre-eclampsia — the last being new hypertension + end-organ damage after 20 weeks that can progress to eclampsia (seizures).
- Safe antihypertensives: labetalol (first-line), nifedipine, methyldopa, IV hydralazine for acute control; never ACE inhibitors or ARBs (fetotoxic).
- Low-dose aspirin from early pregnancy prevents pre-eclampsia in high-risk women; delivery of the placenta is the definitive cure.
- Magnesium sulfate prevents and treats eclamptic seizures; monitor for toxicity (lost reflexes → respiratory depression), with IV calcium gluconate as the antidote.
- NICE guideline NG133 — Hypertension in pregnancy: diagnosis and management.
- The Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Lancet.
- The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. The Lancet.
- Rang & Dale's Pharmacology — Drugs and the reproductive system; antihypertensive agents.
- Katzung Basic & Clinical Pharmacology — Antihypertensive agents; special populations in pregnancy.
- BNF (British National Formulary) — Hypertension in pregnancy; magnesium sulfate; labetalol, nifedipine, methyldopa, hydralazine.
